K, J., M, S., & W, X. (2018). Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: In vitro/vivo evaluation. Dove Medical Press.
Cita Chicago Style (17a ed.)K, Jiang, Shen M, y Xu W. Arginine, Glycine, Aspartic Acid Peptide-modified Paclitaxel and Curcumin Co-loaded Liposome for the Treatment of Lung Cancer: In Vitro/vivo Evaluation. Dove Medical Press, 2018.
Cita MLA (8a ed.)K, Jiang, et al. Arginine, Glycine, Aspartic Acid Peptide-modified Paclitaxel and Curcumin Co-loaded Liposome for the Treatment of Lung Cancer: In Vitro/vivo Evaluation. Dove Medical Press, 2018.
Precaución: Estas citas no son 100% exactas.